Rapid Micro Biosystems Statistics
Total Valuation
RPID has a market cap or net worth of $127.54 million. The enterprise value is $101.86 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, before market open.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RPID has 43.83 million shares outstanding. The number of shares has increased by 1.73% in one year.
| Current Share Class | 39.33M |
| Shares Outstanding | 43.83M |
| Shares Change (YoY) | +1.73% |
| Shares Change (QoQ) | +1.49% |
| Owned by Insiders (%) | 2.70% |
| Owned by Institutions (%) | 17.08% |
| Float | 18.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.23 |
| Forward PS | 4.96 |
| PB Ratio | 2.38 |
| P/TBV Ratio | 2.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.67, with a Debt / Equity ratio of 0.10.
| Current Ratio | 3.67 |
| Quick Ratio | 2.27 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -59.15% and return on invested capital (ROIC) is -35.66%.
| Return on Equity (ROE) | -59.15% |
| Return on Assets (ROA) | -29.89% |
| Return on Invested Capital (ROIC) | -35.66% |
| Return on Capital Employed (ROCE) | -77.86% |
| Revenue Per Employee | $185,822 |
| Profits Per Employee | -$270,613 |
| Employee Count | 163 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 1.33 |
Taxes
In the past 12 months, RPID has paid $22,000 in taxes.
| Income Tax | 22,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +250.60% in the last 52 weeks. The beta is 1.33, so RPID's price volatility has been higher than the market average.
| Beta (5Y) | 1.33 |
| 52-Week Price Change | +250.60% |
| 50-Day Moving Average | 3.49 |
| 200-Day Moving Average | 2.37 |
| Relative Strength Index (RSI) | 38.60 |
| Average Volume (20 Days) | 126,704 |
Short Selling Information
The latest short interest is 344,774, so 0.79% of the outstanding shares have been sold short.
| Short Interest | 344,774 |
| Short Previous Month | 409,487 |
| Short % of Shares Out | 0.79% |
| Short % of Float | 1.82% |
| Short Ratio (days to cover) | 3.82 |
Income Statement
In the last 12 months, RPID had revenue of $30.29 million and -$44.11 million in losses. Loss per share was -$1.00.
| Revenue | 30.29M |
| Gross Profit | 2.28M |
| Operating Income | -46.08M |
| Pretax Income | -50.43M |
| Net Income | -44.11M |
| EBITDA | -43.16M |
| EBIT | -46.08M |
| Loss Per Share | -$1.00 |
Full Income StatementBalance Sheet
The company has $31.26 million in cash and $5.58 million in debt, giving a net cash position of $25.68 million or $0.59 per share.
| Cash & Cash Equivalents | 31.26M |
| Total Debt | 5.58M |
| Net Cash | 25.68M |
| Net Cash Per Share | $0.59 |
| Equity (Book Value) | 54.55M |
| Book Value Per Share | 1.22 |
| Working Capital | 43.74M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 7.53%, with operating and profit margins of -152.12% and -145.63%.
| Gross Margin | 7.53% |
| Operating Margin | -152.12% |
| Pretax Margin | -145.56% |
| Profit Margin | -145.63% |
| EBITDA Margin | -142.48% |
| EBIT Margin | -152.12% |
| FCF Margin | n/a |
Dividends & Yields
RPID does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.73% |
| Shareholder Yield | -1.73% |
| Earnings Yield | -34.59% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for RPID is $8.00, which is 174.91% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 174.91% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |